MARÍA DOLORES
CABALLERO BARRIGÓN
Investigadora en el periodo 1998-2022
University of Pavia
Pavía, ItaliaPublicaciones en colaboración con investigadores/as de University of Pavia (3)
2012
-
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: Development and validation on 593 cases
British Journal of Haematology, Vol. 159, Núm. 2, pp. 164-171
2009
-
Implications of the European organisation for research and treatment of cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care
Clinical Drug Investigation, Vol. 29, Núm. 8, pp. 491-513